CUSIP 92539P101COMQ4 2025
44 filings · latest Aug 14, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Dekabank Deutsche Girozentrale | 24.0K | $344 |
| 4 | Apr 29, 2025 | Millennium Management LLC | 13G | 11.0% | 4.33M | SEC |
| 5 | Apr 17, 2025 | Blackrock, Inc. | 13G/A | 7.0% | 6.18M | SEC |
| 6 | Feb 5, 2025 | State Street Corporation | 13G | 3.8% | 3.24M | SEC |
| 7 | Jan 31, 2025 | Integrated Core Strategies (Us) LLC | 13G/A | 11.0% | 3.92M | SEC |
| 8 | Jan 10, 2025 | Ark Investment Management LLC | 13G/A | — | — | SEC |
| 9 | Nov 18, 2024 | Biotechnology Value Fund L P | 13G | 4.2% | 3.55M | SEC |
| 10 | Nov 12, 2024 | Vanguard Group Inc | 13G/A | 4.7% | 4.01M | SEC |
See the full Schedule 13D/13G history for Verve Therapeutics Inc.
Unlock full history